• 30TH SEPTEMBER 2024

    MHRA Class 2 Medicines Recall: Oxbryta (voxelotor) 500mg Tablets (Pfizer Limited)

    Drug alert number: EL (24)A/44 Date issued: 30 September 2024 Pfizer Limited is recalling all distributed batches of Oxbryta 500 mg Tablets. Pfizer Limited has informed the MHRA that the product is being withdrawn due to emerging data from clinical trials and registry-based studies: Oxbryta (voxelotor) 500mg Tablets (Pfizer Limited) PLGB 00057/1720 DMRC Number: DMRC-32749585

    Read more
    • 27TH SEPTEMBER 2024

    Expiry of SSP072 Cefalexin 500mg tablets

    The Department of Health and Social Care (DHSC) has confirmed that sufficient stock of Cefalexin 500mg tablets are now available to meet normal demand. As a result the Serious Shortage Protocol (SSP), SSP072 Cefalexin 500mg tablets expires at 23.59pm on Friday 27 September 2024. After this date, any prescriptions for Cefalexin 500mg tablets must be

    Read more
    • 27TH SEPTEMBER 2024

    15 products added to the Discount Not Deducted (DND) list from October 2024

    Community Pharmacy England on behalf of pharmacy owners made further applications to the Department of Health and Social Care (DHSC) and the NHS Business Services Authority (NHSBSA), resulting in a further 15 new products being added to the ‘Drugs for which Discount is Not Deducted’ (DND) list from 1 October 2024. This takes the total

    Read more
    • 27TH SEPTEMBER 2024

    Drug Tariff Watch – October 2024

    The Drug Tariff Preface published monthly, lists additions, deletions and other changes to products listed in the Drug Tariff. Below is a summary of the changes coming into effect from 1 October 2024. Key g Special container – This product is a special container and should be dispensed in its complete original pack size. n Item requiring reconstitution

    Read more
    • 26TH SEPTEMBER 2024

    MHRA Drug Safety Update: September 2024

    A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 18 Issue 2 September 2024) has been published and includes articles on: Valproate use in men: as a precaution, men and their partners should use effective contraception Letters and medicine recalls sent to healthcare professionals in August 2024. To see the latest

    Read more